Search Results - "HIRT, S"

Refine Results
  1. 1

    Progression Rate and Ipsilateral Neurological Events in Asymptomatic Carotid Stenosis by HIRT, Liam S

    Published in Stroke (1970) (01-03-2014)
    “…Progression of asymptomatic carotid stenoses with >50% luminal narrowing is associated with an increased risk of stroke. The significance of the progression…”
    Get full text
    Journal Article
  2. 2

    Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial by Eisen, H. J., Kobashigawa, J., Starling, R. C., Pauly, D. F., Kfoury, A., Ross, H., Wang, S.‐S., Cantin, B., Van Bakel, A., Ewald, G., Hirt, S., Lehmkuhl, H., Keogh, A., Rinaldi, M., Potena, L., Zuckermann, A., Dong, G., Cornu‐Artis, C., Lopez, P.

    Published in American journal of transplantation (01-05-2013)
    “…In an open‐label, 24‐month trial, 721 de novo heart transplant recipients were randomized to everolimus 1.5 mg or 3.0 mg with reduced‐dose cyclosporine, or…”
    Get full text
    Journal Article
  3. 3

    Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development by Schiechl, G., Hermann, F. J., Rodriguez Gomez, M., Kutzi, S., Schmidbauer, K., Talke, Y., Neumayer, S., Goebel, N., Renner, K., Brühl, H., Karasuyama, H., Obata‐Ninomiya, K., Utpatel, K., Evert, M., Hirt, S. W., Geissler, E. K., Fichtner‐Feigl, S., Mack, M.

    Published in American journal of transplantation (01-09-2016)
    “…Fibrosis is a major component of chronic cardiac allograft rejection. Although several cell types are able to produce collagen, resident (donor‐derived)…”
    Get full text
    Journal Article
  4. 4

    Inhibition of Innate Co‐Receptor TREM‐1 Signaling Reduces CD4+ T Cell Activation and Prolongs Cardiac Allograft Survival by Schiechl, G., Brunner, S. M., Kesselring, R., Martin, M., Ruemmele, P., Mack, M., Hirt, S. W., Schlitt, H. J., Geissler, E. K., Fichtner‐Feigl, S.

    Published in American journal of transplantation (01-05-2013)
    “…The innate receptor “triggering‐receptor‐expressed‐on‐myeloid‐cells‐1” (TREM‐1) enhances downstream signaling of “pattern recognition receptor” (PRR) molecules…”
    Get full text
    Journal Article
  5. 5

    Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation by von Suesskind-Schwendi, M, Heigel, E, Pfaehler, S, Haneya, A, Schmid, C, Hirt, S W, Lehle, K

    Published in Histology and histopathology (01-07-2016)
    “…Long-term survival of lung allografts is limited by chronic rejection (CR). Oxidative stress (OxS) plays a central role in the development of CR. We…”
    Get full text
    Journal Article
  6. 6

    Dangerous surgical scavenger hunt: the complicated course of a patient with left ventricular assist device and end-stage renal disease undergoing reconstructive flap surgery by Freundt, M, Haneya, A, Schmid, C, Hirt, S

    Published in Perfusion (01-09-2015)
    “…Patients with left ventricular assist devices (LVADs) who develop stage IV sacral pressure sores (SPS) have an increased procedural risk. We present the…”
    Get full text
    Journal Article
  7. 7

    Slight Exercise in Ambulatory LVAD Patients Leads to a Severe Compromise of Hemodynamic Parameters by Camboni, D, Lange, T, Lunz, D, Rupprecht, L, Hilker, M, Hirt, S, Schmid, C

    “…Purpose Effects of exercise during LVAD support are still a matter of research. This study aimed to evaluate exercise in this particular patient population by…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX by von Suesskind-Schwendi, M, Valenti, Verena, Haneya, Assad, Pühler, T, Bewig, B, Schmid, C, Hirt, S W, Lehle, K

    Published in Histology and histopathology (01-10-2013)
    “…Bronchiolitis obliterans (BO) is a progressive and fatal disease after lung transplantation (LTX). Dysregulated growth factor-induced proliferation of…”
    Get full text
    Journal Article
  10. 10

    Impact of the Eurotransplant high-urgency heart allocation system on the outcome of transplant candidates in Germany by Haneya, A, Haake, N, Diez, C, Puehler, T, Cremer, J, Schmid, C, Hirt, S W

    Published in The Thoracic and cardiovascular surgeon (01-03-2011)
    “…In 2000, the Eurotransplant Foundation changed the allocation criteria following the enactment of the German Transplantation Law (GTL). Our study investigated…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Early Administration of FTY720 Prevents Chronic Airway as Well as Vascular Destruction in Experimental Rat Lung Transplantation by Hirt, S.W, von Suesskind-Schwendi, M, Puehler, T, Schmid, C, Lehle, K

    Published in Transplantation proceedings (01-03-2013)
    “…Abstract Background Chronic rejection (CR) in terms of bronchiolitis obliterans (BO) and vascular sclerosis (VS) still represents the major obstacle for…”
    Get full text
    Journal Article
  13. 13

    Clinical research and diagnostic efficacy studies in the oral and maxillofacial radiology literature: 1996-2005 by Kim, I H, Patel, M J, Hirt, S L, Kantor, M L

    Published in Dento-maxillo-facial radiology (01-07-2011)
    “…The aim of this study was to determine the level of evidence that is published in the oral and maxillofacial radiology (OMR) literature. OMR papers published…”
    Get full text
    Journal Article
  14. 14

    Lung transplantation in the fischer 344-wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the rat by von Süßkind-Schwendi, M., Ruemmele, P., Schmid, C., Hirt, S. W., Lehle, K.

    Published in Experimental lung research (01-04-2012)
    “…ABSTRACT Chronic allograft rejection and bronchiolitis obliterans (BO) limited successful long-term outcome after lung transplantation (LTX). Reliable animal…”
    Get full text
    Journal Article
  15. 15

    Herzentnahme zur Transplantation by Schramm, R., Hirt, S. W.

    “…Zusammenfassung Die Herztransplantation ist perspektivisch immer noch der Goldstandard in der Behandlung der therapierefraktären terminalen Herzinsuffizienz…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation by Hubner, R. H, Meffert, S, Mundt, U, Bottcher, H, Freitag, S, El Mokhtari, N. E, Pufe, T, Hirt, S, Folsch, U. R, Bewig, B

    Published in The European respiratory journal (01-03-2005)
    “…Bronchiolitis obliterans syndrome (BOS) is a severe complication after lung transplantation (LTX). In a retrospective cohort study 12 stable healthy recipients…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Successful use of a percutaneous miniaturized extracorporeal life support system as a bridge and assistance to left ventricular assist device implantation in a patient with severe refractory cardiogenic shock by Haneya, A, Philipp, A, Puehler, T, Camboni, D, Hilker, M, Hirt, SW, Schmid, C

    Published in Perfusion (01-01-2012)
    “…We present a 51-year-old man with cardiogenic shock in whom a percutaneous extracorporeal life support system (ECLS) was inserted to restore cardiopulmonary…”
    Get full text
    Journal Article
  20. 20

    Surfactant replacement in reperfusion injury after clinical lung transplantation by STRÜBER, M, HIRT, S. W, CREMER, J, HARRINGER, W, HAVERICH, A

    Published in Intensive care medicine (01-08-1999)
    “…Reperfusion injury remains a significant risk factor in the immediate postoperative course after lung transplantation. We report on our initial clinical…”
    Get full text
    Journal Article